CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury

Journal of Neuroscience

Volumn 31, Issue 15, 2011, Pages 5865-5875

  van Steenwinckel, Juliette ^a   Goazigo, Annabelle Reaux Le ^a   Pommier, Blandine ^a   Mauborgne, Annie ^a   Dansereau, Marc André ^b   Kitabgi, Patrick ^a   Sarret, Philippe ^b   Pohl, Michel ^a   Parsadaniantz, Stéphane Mélik ^a  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CAPSAICIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; N [2 [[1 [4 (1,3 BENZODIOXOL 5 YL) 4 HYDROXYCYCLOHEXYL] 4 ETHOXY 3 PYRROLIDINYL]AMINO] 2 OXOETHYL] 3 (TRIFLUOROMETHYL)BENZAMIDE; VANILLOID RECEPTOR 1 ANTAGONIST;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; IMMUNOREACTIVITY; INFLAMMATION; MALE; NERVE COMPRESSION; NEUROMODULATION; NEUROPATHIC PAIN; NEWBORN; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SECRETORY VESICLE; SENSORY NERVE; SPINAL CORD DORSAL HORN; SYNAPSE VESICLE; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CHEMOKINE CCL2; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROSCOPY, ELECTRON; NEURALGIA; NEURONS; PERIPHERAL NERVES; PROTEIN KINASE INHIBITORS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCIATIC NERVE; SPINAL CORD; SYNAPTIC VESICLES;

EID: 79955769305     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5986-10.2011     Document Type: Article

References (47)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947-7952.
2. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
3. Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 5:48.
4. Bhat NR, Zhang P, Lee JC, Hogan EL (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-a gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633-1641.
5. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, Collins R, Leffet L, Gallagher K, Feldman P, Collier P, Stow M, Gu X, Baribaud F, Shin N, Thomas B, Burn T, Hollis G, Yeleswaram S, Solomon K, Friedman S, Wang A, Xue CB, Newton RC, Scherle P, Vaddi K (2005) Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 175:5370-5378.
6. Cesselin F, Bourgoin S, Artaud F, Hamon M (1984) Basic and regulatory mechanisms of in vitro release of Met-enkephalin from the dorsal zone of the rat spinal cord. J Neurochem 43:763-774.
7. Chan-Palay V, Palay SL (1977) Ultrastructural identification of substance P cells and their processes in rat sensory ganglia and their terminals in the spinal cord by immunocytochemistry. Proc Natl Acad Sci U S A 74:4050-4054.
8. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
9. Cheng AW, Kong LW, Tung EK, Siow NL, Choi RC, Zhu SQ, Peng BH, Tsim KW (2003) cDNA encodes Xenopus P2Y(1) nucleotide receptor: expression at the neuromuscular junctions. Neuroreport 14:351-357.
10. Chun KS, Surh YJ (2004) Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemo-prevention. Biochem Pharmacol 68:1089-1100.
11. Coimbra A, Ribeiro-da-Silva A, Pignatelli D (1984) Effects of dorsal rhizo-tomy on the several types of primary afferent terminals in laminae I-III of the rat spinal cord. An electron microscope study. Anat Embryol (Berl) 170:279-287.
12. Cuello AC, Jessell TM, Kanazawa I, Iversen LL (1977) Substance P: localization in synaptic vesicles in rat central nervous system. J Neurochem 29:747-751.
13. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, Mauborgne A, Rostene W, Kitabgi P, Beaudet N, Sarret P, Melik-Parsadaniantz S (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106:757-769.
14. Galan A, Lopez-Garcia JA, Cervero F, Laird JM (2002) Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carra-geenan in rodents. Neurosci Lett 322:37-40.
15. Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, Park JY, Lind AL, Ma Q, Ji RR (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29:4096-4108.
16. Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, Melik-Parsadaniantz S (2005) Constitutive expression of CCR2 chemo-kine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem 95:1023-1034.
17. Gosselin RD, Dansereau MA, Pohl M, Kitabgi P, Beaudet N, Sarret P, Mélik Parsadaniantz S (2008) Chemokine network in the nervous system: a new target for pain relief. Curr Med Chem 15:2866-2875.
18. Jeon SM, Lee KM, Cho HJ (2009) Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain. Brain Res 1251:103-111.
19. Ji RR, Befort K, Brenner GJ, Woolf CJ (2002) ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregu-lation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 22:478-485.
20. Ji RR, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696-705.
21. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24:7353-7365.
22. Jung H, Toth PT, White FA, Miller RJ (2008) Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J Neurochem 104:254-263.
23. Ma JY, Zhao ZQ (2002) The involvement of glia in long-term plasticity in the spinal dorsal horn of the rat. Neuroreport 13:1781-1784.
24. Mauborgne A, Lutz O, Legrand JC, Hamon M, Cesselin F (1987) Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. J Neurochem 48: 529-537.
25. Maxwell DJ, Christie WM, Short AD, Storm-Mathisen J, Ottersen OP (1990) Central boutons of glomeruli in the spinal cord of the cat are enriched with L-glutamate-like immunoreactivity. Neuroscience 36:83-104.
26. Miller RJ, Jung H, Bhangoo SK, White FA (2009) Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 194:417-449.
27. Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23-36.
28. Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, Foster AC, Naeve GS, Maier SF, Watkins LR (2004) Evidence that exogenous and endogenous frac-talkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294-2302.
29. Milligan E, Zapata V, Schoeniger D, Chacur M, Green P, Poole S, Martin D, Maier SF, Watkins LR (2005) An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci 22:2775-2782.
30. Myers RR, Campana WM, Shubayev VI (2006) The role of neuroinflamma-tion in neuropathic pain: mechanisms and therapeutic targets. Drug Dis-cov Today 11:8-20.
31. Pedersen LM, Jacobsen LM, Mollerup S, Gjerstad J (2010) Spinal cord long-term potentiation (LTP) is associated with increased dorsal horn gene expression of IL-1beta, GDNF and iNOS. Eur J Pain 14:255-260.
32. Pohl M, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F (1989) Neonatal capsaicin treatment abolishes the modulations by opi-oids of substance P release from rat spinal cord slices. Neurosci Lett 96:102-107.
33. Pohl M, Lombard MC, Bourgoin S, Carayon A, Benoliel JJ, Mauborgne A, Besson JM, Hamon M, Cesselin F (1989) Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord. Neuropeptides 14:151-159.
34. Pohl M, Benoliel JJ, Bourgoin S, Lombard MC, Mauborgne A, Taquet H, Carayon A, Besson JM, Cesselin F, Hamon M (1990) Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal capsaicin. J Neurochem 55:1122-1130.
35. Ribeiro-da-Silva A, Coimbra A (1982) Two types of synaptic glomeruli and their distribution in laminae I-III of the rat spinal cord. J Comp Neurol 209:176-186.
36. Ribeiro-da-Silva A, Tagari P, Cuello AC (1989) Morphological characterization of substance P-like immunoreactive glomeruli in the superficial dorsal horn of the rat spinal cord and trigeminal subnucleus caudalis: a quantitative study. J Comp Neurol 281:497-515.
37. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-475.
38. Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
39. Song XS, Cao JL, Xu YB, He JH, Zhang LC, Zeng YM (2005) Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic painin rats. Acta Pharmacol Sin 26:789-798.
40. Tanaka T, Minami M, Nakagawa T, Satoh M (2004) Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 48:463-469.
41. Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, McMahon SB (2009) CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13:263-272.
42. Tsuda M, Ueno H, Kataoka A, Tozaki-Saitoh H, Inoue K (2008) Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56: 378-386.
43. White FA, Miller RJ (2010) Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain. Brain Behav Immun 24:859-865.
44. White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, Miller RJ (2005) Excitatory monocyte chemoattractant protein-1 signaling isup-regulatedinsensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 102: 14092-14097.
45. White FA, Jung H, Miller RJ (2007) Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A 104:20151-20158.
46. Zhao P, Waxman SG, Hains BC (2007) Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microclimate by cysteine cysteine chemokine ligand 21. J Neurosci 27: 8893-8902.
47. Zhuang ZY, Gerner P, Woolf CJ, Ji RR (2005) ERK is sequentially activated in neurons, microglia, and astrocytesby spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114: 149-159.